文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 高等教育 > 医学 > 2007:ESC:Guidelines on valvular heart disease
侵权投诉

2007:ESC:Guidelines on valvular heart disease

Guidelines on valvular heart disease

ESCGuidelinesProstheticvalves

Patientswhohaveundergonepreviousvalvesurgeryrep-resentanimportantproportionofpatientswithVHD,accountingfor28%ofallpatientswithVHDintheEuroHeartSurvey.3Theextentofprosthesis-relatedcompli-cationsinpatientoutcomeaftersurgeryemphasizestheimportanceofoptimizingthechoiceofthevalvesubstituteaswellasthesubsequentmanagementofpatientswithprostheticvalves.

Choiceofprostheticvalve

Thereisnoperfectvalvesubstitute.Allinvolvesomecom-promiseandallintroducenewdiseaseprocesses,whethertheyaremechanicalorbiological.Thelatterincludexeno-grafts,homografts,andautografts.Autograftsandhomo-graftsintheaorticpositionprovidethebesteffectiveori cearea(EOA).StentlessbioprosthesesprovidebetterEOAthanstentedbioprostheses,whicharerelativelysteno-ticinthesmallsizes(annulussize 21mm).Modernmech-anicalvalvesprovidebetterhaemodynamicperformancethanstentedbioprostheses.

Allmechanicalvalvesrequirelong-termanticoagulation.Biologicalvalvesarelessthrombogenicanddonotrequirelong-termanticoagulationunlessthereareotherindi-cations,e.g.persistentatrial brillation.However,allaresubjecttostructuralvalvedeterioration(SVD)overtime.Tworandomizedtrials,whichbeganinthe1970s,compar-ingnowobsoletemodelsofmechanicalandbioprostheticvalvesfoundnosigni cantdifferenceinratesofvalvethrombosisandthrombo-embolism,inaccordancewithnumerousindividualvalveseriesintheliterature.Long-termsurvivalwasalsoverysimilar.147,164Arecentmeta-analysisofmechanicalandbioprostheticvalveseriesfoundnodifferenceinsurvivalwhenageandriskfactorsweretakenintoaccount.165

Apartfromhaemodynamicconsiderations,choicebetweenamechanicalvalveandabioprosthesisinadultsisthusdeter-minedprimarilybyassessingtheriskofanticoagulant-relatedbleedingwithamechanicalvalvevs.theriskofSVDwithabioprosthesis.166,167TheformerisdeterminedmainlybythetargetINRchosen,thequalityofanticoagulationcontrol,theconcomitantuseofaspirin,andthepatient’sownriskfactorsforbleeding.168TheriskofSVDmusttakeintoaccountthegradualdeteriorationinperformancestatuswithincreasingSVD,theriskofre-operationandlengthoftherecoveryperiodaftersubsequentsurgery.

Homograftsandpulmonaryautograftsaremainlyusedintheaorticposition,thoughevenheretheytogetheraccountforlessthan0.5%ofaorticvalvereplacementsinmostlargedatabases.Likebioprostheses,homograftsaresubjecttoSVD.169Besidestechnicalconcerns,limitedavail-abilityandincreasedcomplexityofreoperationcontributetorestricttheuseofhomograftstocomplicatedaorticvalveendocarditis.

Althoughthepulmonaryautograftintheaorticposition(Rossoperation)providesexcellenthaemodynamics,itrequiresspeci cexpertiseandhasseveraldisadvantages:theriskofSVDinthehomograftinthepulmonaryposition,theriskofmoderateARduetodilatationoftheaorticroot,andtheriskofrheumaticinvolvement.Apartfromshort-termadvantagesinselectedyoungadults,suchas

253

professionalathletes,themainadvantageoftheautograftisingrowingchildren,asthevalveandnewaorticannulusappeartogrowwiththechild.170However,thehomograftpulmonaryvalvereplacementdoesnotand,therefore,usuallyneedsreplacementasthechildgetsbigger.

Inpractice,thechoiceisbetweenmechanicalprosthesisandbioprosthesisinmostpatients.Ratherthansettingarbi-traryagelimits,prosthesischoiceshouldbeindividua-lized167anddiscussedindetailwiththepatient,takingintoaccountthefollowingfactors(Tables15,16):

(1)Lifeexpectancyshouldbeestimatedaccordingto

countryandpatient’sage,andtakeintoaccountcomorbidities.

(2)Amechanicalvalveshouldberecommendedifamech-anicalvalveisimplantedonanothervalveandshould

Table15Choiceoftheprosthesis:infavourofmechanicalprosthesisa

Class

Desireoftheinformedpatient

IC

andabsenceofcontraindicationforlong-termanticoagulation

PatientsatriskofacceleratedSVDb

ICPatientalreadyonanticoagulationbecauseICofothermechanicalprosthesis

PatientsalreadyonanticoagulationbecauseIIaCathighriskforthrombo-embolismcAge,65–70andlonglifeexpectancyd

IIaCPatientsforwhomfutureredovalvesurgeryIIaC

wouldbeathighrisk(duetoLVdysfunction,previousCABG,multiplevalveprosthesis)

CABG¼coronaryarterybypassgrafting,LV¼leftventricular,SVD¼structuralvalvedeterioration.a

Thedecisionisbasedontheintegrationofseveralofthefactorsgiveninthetable.b

Youngage,hyperparathyroidism.c

Riskfactorsforthrombo-embolism:severeLVdysfunction,atrial bril-lation,previousthrombo-embolism,hypercoagulablestate.d

Accordingtoage,gender,thepresenceofcomorbidity,andcountry-speci clifeexpectancy.

Table16Choiceoftheprosthesis:infavourofbioprosthesisa

Class

Desireoftheinformedpatient

ICUnavailabilityofgood-qualityanticoagulationIC

(contraindicationorhighrisk,unwillingness,complianceproblems,lifestyle,occupation)Re-operationformechanicalvalvethrombosisinaICpatientwithprovenpooranticoagulantcontrolPatientforwhomfutureredovalvesurgerywouldIIaCbeatlowrisk

Limitedlifeexpectancyb,severecomorbidity,orIIaCage.65–70

Youngwomancontemplatingpregnancy

IIbC

a

Thedecisionisbasedontheintegrationofseveralofthefactorsgiveninthetable.b

Accordingtoage,gender,thepresenceofcomorbidity,andcountry-speci clifeexpectancy.

上一页第24页

你可能喜欢

  • 外科诊疗常规
  • 心力衰竭课件
  • 感染性心内膜炎指南
  • 最全人体解剖图
  • 高血压PPT
  • 执业医师
  • 知情同意书

热门文档

相关文档

  • 心脏瓣膜病诊疗指南解读2

    Guidelines for the Management of Patients 年 With Valvular Heart Disease (美国) 美国) 2007年:ESC Guidelines on the Management of Valvular Heart 年 Disease...

  • 心脏瓣膜病诊疗指南解读1

    Guidelines for the Management of Patients 年 With Valvular Heart Disease (美国) 美国) 2007年:ESC Guidelines on the Management of Valvular Heart 年 Disease...

  • 重点!心脏瓣膜病诊疗指南解读

    2006年: ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease (美国) ? 2007年:ESC Guidelines on the Management of Valvular Heart...

  • Valvular_Heart_Disease_IM_8-12

    VALVULAR HEART DISEASE 52页 7下载券 Valvular Heart Disease 暂无评价 87页 1下载券 2007:ESC:Guidelines ... 39页 1下载券 A403-A418 Valvular Hea... 16...

  • 2014ESC-Revascularization

    No part of the ESC Guidelines may be translated or reproduced in any form..., Working Group on Thrombosis, Working Group on Valvular Heart Disease. ...

  • 2011ESC妊娠期心血管疾病诊疗指南

    10.1093/eurheartj/ehr218 ESC GUIDELINES ESC Guidelines on the management ...Valvular Heart Disease, Cardiovascular Pharmacology and Drug Therapy, Acute Cardiac...

  • 心力衰竭与感染

    Guidelines on the prevention, diagnosis, and ...(ESCMID) and the International Society of ...on valvular heart disease: focused update on ...

  • eurheartj.ehu281.full

    10.1093/eurheartj/ehu281 ESC GUIDELINES 2014 ESC Guidelines on the ...and Cardiac Computed Tomography, Peripheral Circulation, Valvular Heart Disease....

  • 2012ESC急慢性心衰治疗指南

    European Heart Journal doi:10.1093/eurheartj/ehs104 ESC GUIDELINES ESC ...Valvular Heart Disease Councils: Cardiovascular Imaging, Cardiovascular Nursing and...

  • 2012 ESC 心衰新指南(英文)

    Valvular Heart Disease Councils: Cardiovascular Imaging, Cardiovascular Nursing and...No part of the ESC Guidelines may be translated or reproduced in any form...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email